Top 5 Things you need to know from outside the EU this week: (Truvada, Nanoclews, CRISPR-Cas9)

05/09/2015 - 3 minutes

Oh hey there…another Top 5 topics you need to know from outside Europe this week.

Enjoy and if you have time, give us some feedback!

BREAKTHROUGH TABLET PREVENTS HIV INFECTION IN UP TO 92% OF HIGH RISK CASES

HIV Tablet ‘Truvada‘: San Francisco health Insurance firm Kaiser Permanente published a study on Tuesday showed out of the 657 ‘high risk of HIV’ patients taking Truvada, none contracted HIV over a 3-year period marking a massive milestone in the battle against AIDS.

READ MORE ON BUSINESS INSIDER UK… 

CRISPR CAS-9 GENOME EDITING COMPLEX DELIVERED TO NUCLEUS BY DNA VEHICLE

CRISPR-Cas9 genome editing complex delivered to cell nucleus by engineered extracellular DNA-based transport package dubbed ‘Nanoclews’. Shown to be an efficient delivery method of Cas9, it has been demonstrated both in vivo and in vitro.

READ MORE IN GENENGNEWS…

WATCH ACTIN-MYOSIN INTERACT IN VIVO IN SUPER-HIGH RESOLUTION

“Scientists can now watch dynamic biological processes with unprecedented clarity in living cells using new imaging techniques.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member